AB-359

N/A

Report date: 2025/03/18 16:59:53

Base Information

Drug NameAB-359
Drug Alias NameCis-targeted IL-2 fusion protein(Asher Biotherapeutics)AB-359
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 stimulantsCD8-positive T-Lymphocytes stimulants
TargetsInterleukin-2
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsher Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAsher Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A